Evidence map›Paper›PMID 34123576›Full record

ArticleOncoimmunology2021

Prognostic image-based quantification of CD8CD103 T cell subsets in high-grade serous ovarian cancer patients.

S T Paijens, A Vledder, D Loiero, E W Duiker, J Bart, A M Hendriks, M Jalving, H H Workel, H Hollema, N Werner and 9 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncoimmunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.0field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Development of [EJNMMI research · 2023
    Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 2 countries.

S T PaijensDepartment of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
A VledderDepartment of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
D LoieroDepartment of Pathology and Molecular Pathology, University Hospital and University of Zurich, Zurich, Switzerland.
E W DuikerDepartment of Pathology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
J BartDepartment of Pathology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
A M HendriksDepartment of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
M JalvingDepartment of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
H H WorkelDepartment of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
H HollemaDepartment of Pathology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
N WernerDepartment of Pathology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
A PlatDepartment of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
G B A WismanDepartment of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.ORCID 0000-0002-4830-3401
R YigitDepartment of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
H ArtsDepartment of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
A J KruseDepartment of Obstetrics and Gynecology, Isala Hospital Zwolle, Zwolle, The Netherlands.
N M de LangeDepartment of Obstetrics and Gynecology, Isala Hospital Zwolle, Zwolle, The Netherlands.
V H KoelzerDepartment of Pathology and Molecular Pathology, University Hospital and University of Zurich, Zurich, Switzerland.
M de BruynDepartment of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
H W NijmanDepartment of Obstetrics and Gynecology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.ORCID 0000-0002-1821-3042
University Medical Center Groningen · NLIsala · NLUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CD103-positive tissue resident memory-like CD8

Indexed as

Cystadenocarcinoma, SerousOvarian NeoplasmsCD8-Positive T-LymphocytesFemaleHumansLymphocytes, Tumor-InfiltratingPrognosisT-Lymphocyte SubsetsCD8CD103 t celldigital quantificationhigh grade serous ovarian canceroverall survivalprognosistissue resident memory t cells

Identifiers

PMID34123576
PMCPMC8183551
OpenAlexW3168917677

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.